Key result
New 3-class biomarker framework pairs with imaging to categorize AAA presence, growth, and morphology.
Why the study?
Current clinical management of AAA relies on imaging for diagnosis and growth monitoring alongside surgical exclusion of larger aneurysms. A disease-specific framework is needed to systematically integrate evolving multianalyte circulating biomarker assessments with clinical and imaging data to identify active biologic processes influencing AAA natural history.
Proposes a novel three-class framework integrating circulating biomarkers with aortic imaging features to better detect, monitor, and identify therapeutic targets for abdominal aortic aneurysms.
Answers are grounded in this paper and cite their sources.
May aid AAA risk stratification via biomarker-imaging pairs; hypothesis-generating and requires prospective validation before clinical use.
Abdominal aortic aneurysm (AAA) is a multifactorial disease characterized by progressive remodeling of the aortic wall. Current clinical management includes screening ultrasound for diagnosis, and routine aortic imaging to monitor growth in patients with small AAA and surgical exclusion of larger AAA. With the evolution of a diverse array of multianalyte assessments from peripheral blood, comprehensive assessments of circulating biomarkers in patients with AAA is possible. In the context of this dynamic disease process, circulating markers – paired with clinical and imaging data – provide an opportunity to identify specific active biologic processes that influence the natural history of the disease. We propose a disease-specific framework for understanding relationships between circulating markers and imaging within a novel three class structure. Class I associations correlate with aortic size and presence of AAA and may be related to the mechanisms of initial formation. Class II associations track with change in aneurysm MTD and may be related to mechanisms of AAA growth and rupture risk. Class II may be clinically relevant for the identification of targets for modification that could alter the natural history of established AAA. Class III associations relate to static or dynamic morphologic features such as mural thrombus or calcifications that have less well-defined associations with clinical outcomes. Identified and appropriately classified markers can provide specific avenues for novel therapeutic and diagnostic options to reduce morbidity and mortality in patients with AAA.
No takes yet. Share an insight, caveat, or question.
Lindsey et al. (2026) conducted a review in Abdominal aortic aneurysm. Circulating biomarker classification framework was evaluated. A novel 3-class framework pairs circulating biomarkers with imaging to categorize associations with abdominal aortic aneurysm presence (Class I), growth (Class II), and morphology (Class III).
Synapse has enriched 10 related papers. Consider them for comparative context: